Ad hoc announcement pursuant to Art. 53 LR
ZUG, Switzerland -- (BUSINESS WIRE) --
Galderma Group AG, the pure-play dermatology category leader, today announced its financial results for the first ...
Detailed results from the phase III ARCADIA 1 and 2 trials evaluating the safety and efficacy of nemolizumab in atopic dermatitis were published for the first time in The Lancet1
Data from this ph...